⌘K
TRIMTECH Therapeutics logo

TRIMTECH Therapeutics

Healthcare & Life Sciences

Recent Finacing

Seed

Recent Raise

$32M

TRIMTECH Therapeutics is a biotech company developing targeted protein degradation therapeutics for neurodegenerative diseases using TRIMTAC degrader molecules.

Total Funding

$32M

Headquarters

Cambridge, United Kingdom

Founded

N/A

Website

trimtechtherapeutics.com

Focus Areas

Biotech
targeted protein degradation
neurodegenerative diseases
CNS-penetrant therapeutics
TRIMTAC degrader molecules
E3 ubiquitin ligase

Investors

Pfizer Ventures logo
Eli Lilly and Company logo
SV Health Investors logo
Cambridge Innovation Capital logo
M Ventures logo
Cambridge Enterprise Ventures logo
MP Healthcare Venture Management logo